1 option
Mirabegron extended-release tablets (Myrbetriq) : treatment of overactive bladder (OAB) with symptoms of urgency, urgency incontinence and urinary frequency / Canadian Agency for Drugs and Technologies in Health, issuing body.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.